In this regard, studies have shown that UBE2S promotes the development of hepatocellular carcinoma by inhibiting the p53 signaling pathway by enhancing the ubiquitination of p53 (Pan et al. 2018). The gene discussed is UBE2S; the disease is hepatocellular carcinoma.